# A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma

> **NCT00980382** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Center, Korea** · enrollment: 85 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** S-1, Docetaxel

## Key facts

- **NCT ID:** NCT00980382
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2009-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980382, "A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00980382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*